INTRODUCTION:
The therapeutic scheme of triclabendazole (TCBZ), the recommended anthelmintic against
Eighty-four Peruvian children with
A parasitological cure was obtained in 100% of individuals from Group I and 95% of individuals from Group II. The most common adverse event was biliary colic.
The tested scheme was efficacious and tolerable, and it might be an optimal scheme in the region. To the best of our knowledge, this represents the largest series of children treated with TCBZ in a non-hospital setting.
Palabras clave